Crixus BH3 Acquisition Company (BHAC) Sells Sponsor Economics
by Nicholas Alan Clayton on 2023-09-28 at 7:46am

Crixus BH3 (NASDAQ:BHAC) announced in an 8-K this morning that it will sell its most of its sponsor shares and warrants to a new sponsor entity, which will continue to lead the SPAC.

The new sponsor is to buy up 3,746,303 promote shares (65.1%) and 4,160,000 (65%) of the original sponsor’s private placement warrrants for $16,288.27 and will appoint six of the SPAC’s seven new Board members.

The new team has not been named, but this would appear to be a transaction occurring within the corporate family.

The sole Board member to remain after the takeover, Eric Edidin, is executive chairman of BH3 Management which backed Crixus BH3, and presumably has a relationship with incoming sponsor Focus Impact BHAC, as the SPAC is to be renamed “Focus Impact BH3”.

BHC Management is a real estate investor that viewed its strategy with Crixus as seeking out targets within this same scope.

Nonetheless, the agreement is also conditioned upon the SPAC’s underwriters Guggenheim and BTIG waiving their deferred fees and the new team receiving a working capital loan of at least $1.2 million.

Crixus BH3 will in turn receive a reimbursement of $175,440 in expenses it incurred in connection with loaning the SPAC funds for extension in December 2022.

In light of the changes, the SPAC has also postponed its tomorrow’s extension vote to 9 am ET October 6. This is the company’s current transaction deadline, but pushing it back may give investors time to engage with the new team and its ideas before making final redemption decisions by 5pm ET October 4.

The SPAC notes that it believes that it will need $35 million to $40 million in trust to complete a deal. Crixus’ new ownership would accept a trust balance below $35 million as a result of the meeting but not under $20 million. It currently has about $52 million in trust after having seen 78.2% of shares redeemed in an earlier vote.

Crixus has made such predictions before and also flirted with liquidation. Ahead of a December vote, it predicted it would need between $75 million and $100 million to complete a deal and noted it would not accept a redemption result putting it below $45 million.

Last month, it announced it would liquidate early, but reversed this about one week later.

The SPAC’s previous team, which was largely made up of BH3 executives did not come to a definitive agreement within their tenure. But, perhaps some new officers tag-teamed in will get a deal over the line.

 

Recent Posts
by Nicholas Alan Clayton on 2024-05-03 at 3:56pm

Real estate marketplace Opendoor (NASDAQ:OPEN) is poised to be the latest de-SPAC to take a double-digit jump on earnings as it heads towards the weekend up +10%, having spiked as high as +27% earlier in the day. The movement comes as the former Social Capital II target reported progress towards profitability despite a high rates...

by Nicholas Alan Clayton on 2024-05-03 at 8:02am

At the SPAC of Dawn Coinbase (NASDAQ:COIN) notched a surprise profit of over $1.5 billion in the first quarter of 2024, well exceeding estimates, demonstrating the powerful effect of publicly traded ETFs have had on crypto marketplaces since the start of the year. The result has pushed the company to bump up its own guidance...

by Nicholas Alan Clayton on 2024-05-02 at 3:03pm

Online casino and sports company Rush Street (NYSE:RSI) is up +18.4% in trading today on the back of a solid first quarter earnings release, bringing the company’s stock to its highest price since the second half of 2022 (currently $7.60). This makes it the latest in a line of 2020 and 2021 de-SPACs that have...

by Nicholas Alan Clayton on 2024-05-02 at 10:56am

Mountain Crest V (NASDAQ:MCAG) broke a long dealmaking silence by SPACs this morning, albeit with a non-binding agreement to combine with Seoul-based diagnostic biotech firm CUBEBIO. The term sheet would give the company a $620 million pre-transaction equity value and help accelerate the rollout of CUBEBIO’s CEED-NOVUS cancer screening kit products. The company signed an...

by Nicholas Alan Clayton on 2024-05-02 at 8:45am

Churchill Capital Corp IX (NASDAQ:CCIXU) announced the pricing of its $250 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “CCIXU”, Thursday, May 2, 2024. The new SPAC will conduct a broad search and has not limited itself to any particular sector or focus, but it plans to...

logo

Copyright © 2023 SPACInsider, Inc. All Rights Reserved